`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`PAR PHARMACEUTICAL, INC.,
`
`Petitioner,
`
`v.
`
`NOVARTIS AG,
`
`Patent Owner.
`
`
`
`Case IPR2016-00084
`
`Patent No. 5,665,772
`
`
`
`
`
`
`
`DECLARATION IN SUPPORT OF PATENT OWNER NOVARTIS’S
`MOTION FOR PRO HAC VICE ADMISSION OF JARED L. STRINGHAM
`UNDER 37 C.F.R. § 42.10
`
`
`
`
`
`NOVARTIS EXHIBIT 2189
`Par v Novartis, IPR 2016-00084
`Page 1 of 4
`
`
`
`
`
`
`
`
`1.
`
`I, Jared L. Stringham, am more than twenty-one years of age, am
`
`competent to present this declaration, and have personal knowledge of the facts
`
`set forth herein.
`
`2.
`
`This declaration is given in support of Patent Owner Novartis’s
`
`Motion for Pro Hac Vice Admission.
`
`3.
`
`I am an associate at the law firm of Fitzpatrick, Cella, Harper &
`
`Scinto, in the firm’s New York office.
`
`4.
`
`I have been a patent litigation attorney for more than six years. I
`
`have been litigating patent cases for this entire time period and have been
`
`involved in numerous cases involving patent validity and infringement, at both
`
`the District Court and the Federal Circuit. A significant portion of my work has
`
`involved biological and chemical arts, with particular emphasis on
`
`pharmaceuticals. I am, therefore, an experienced litigating attorney.
`
`5.
`
`I am a member in good standing of the State Bar of New York. I
`
`have never been suspended or disbarred from practice before any court or
`
`administrative body.
`
`6.
`
`No court or administrative body has ever denied my application for
`
`admission to practice before it.
`
`NOVARTIS EXHIBIT 2189
`Par v Novartis, IPR 2016-00084
`Page 2 of 4
`
`
`
`
`7.
`
`No court or administrative body has ever imposed sanctions or
`
`contempt citations on me.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37
`
`C.F.R.
`
`9.
`
`I understand that I will be subject to the Office’s Rules of
`
`Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary
`
`jurisdiction under 37 C.F.R. § 11.19(a).
`
`10.
`
`I have not applied to appear pro hac vice in another proceeding
`
`before the Office in the last three (3) years.
`
`11.
`
`I have an established familiarity with the subject matter at issue in
`
`this proceeding. I have been involved consistently and substantively in the
`
`instant matter and District Court litigation involving the same patent for over a
`
`year. I have read in detail and understand the Petition filed by Petitioner and the
`
`challenged patent, U.S. Patent 5,665,772 (“the ’772 patent”). I have also
`
`reviewed all the exhibits relied upon by Petitioner and Patent Owner in this
`
`proceeding, including each of the references cited in instituted Grounds 1 and 2.
`
`NOVARTIS EXHIBIT 2189
`Par v Novartis, IPR 2016-00084
`Page 3 of 4
`
`
`
`
`12.
`
`I have engaged in extensive strategic and substantive discussions
`
`regarding this proceeding with Nicholas N. Kallas, who is the lead counsel for
`
`Patent Owner in this proceeding and a registered practitioner (Reg. No. 31,530).
`
`I have also engaged in extensive substantive discussions with experts
`
`concerning issues relevant to this proceeding.
`
`l3.
`
`Therefore, I have an established familiarity with the subject matter
`
`at issue in this proceeding.
`
`14.
`
`I declare further that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true and further that these statements were made with the
`
`knowledge that willful false statements and the like so made are punishable by
`
`fine or imprisonment, or both, under Section 1001 of Title 18 of the United
`
`States Code, and that such willful false statements may jeopardize the validity
`
`of the ’772 patent.
`
`Dated: October 18, 2016
`
`47I 5Jared L.
`
`tringham
`
`NOVARTIS EXHIBIT 2189
`Par v Novartis, IPR 2016-00084
`Page 4 of 4